Log in

Assessment of Benzodiazepine (BZD) Use Among Nursing Home Residents by Liquid Chromatography-Tandem Mass Spectrometry, Nursing Questionnaires, and Examining Additional Mental Health Problems of BZD Users

  • Original Article
  • Published:
International Journal of Mental Health and Addiction Aims and scope Submit manuscript

Abstract

This study aimed at evaluating the extent of benzodiazepine (BZD) consumption among nursing home residents and examining additional mental health problems. Urine samples were collected in nursing homes in a border region between Austria and Germany and analyzed for BZD using a liquid chromatographic-tandem mass spectrometric method (LC–MS/MS). In addition, a questionnaire was applied to the residents including the ICD-10 symptom rating scale; nursing staff filled out a further questionnaire on residents’ consumption of addictive drugs. Of 301 urine samples collected in 33 nursing homes, 103 (34.2%) were BZD positive. BZD users showed significantly higher values for depression and anxiety. Nursing staff reported consumption of addictive drugs in 29 (37.2% of BZD positives) with almost entirely BZD use. In nearly 4% of BZD users, nursing staff indicated drug abuse/dependence. BZD use appears to be rather common in nursing homes and nurses apparently do not recognize the addictive potential of BZD sufficiently. Interventions should aim at a reduction of BZD prescriptions by sensitizing primary care physicians and nursing staff.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Aebi, C. (2002). Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi-Center Studie. Retrieved October 07, 2021, from https://www.memoryclinic.ch/fileadmin/user_upload/Memory_Clinic/Literatur/2002/Aebi_2002.pdf

  • Alvim, M. M., Da Cruz, D. T., Vieira, Md. T., Bastos, R. R., & Leite, I. C. G. (2017). Prevalence of and factors associated with benzodiazepine use in community-resident elderly persons. Revista Brasileira de Geriatria e Gerontologia, 20(4), 463–473.

    Article  Google Scholar 

  • American Geriatrics Society Beers Criteria® Update Expert Panel, Fick, D. M., Semla, T. P., Steinman, M., Beizer, J., Brandt, N., et al. (2019). American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694.

    Article  Google Scholar 

  • Assem-Hilger, E., Jungwirth, S., Weissgram, S., Kirchmeyr, W., Fischer, P., & Barnas, C. (2009). Benzodiazepine use in the elderly: An indicator for inappropriately treated geriatric depression? International Journal of Geriatric Psychiatry, 24(6), 563–569.

    Article  PubMed  Google Scholar 

  • Azermai, M., Elseviers, M., Petrovic, M., van Bortel, L., & Stichele, R. V. (2011). Geriatric drug utilisation of psychotropics in Belgian nursing homes. Human Psychopharmacology: Clinical and Experimental, 26(1), 12–20.

    Article  PubMed  Google Scholar 

  • Bartlett, G., Abrahamowicz, M., Grad, R., Sylvestre, M.-P., & Tamblyn, R. (2009). Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Family Practice, 10(1), 1.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bell, J. S., Lavikainen, P., Korhonen, M., & Hartikainen, S. (2010). Benzodiazepine discontinuation among community-dwelling older people: A population-based cohort study. European Journal of Clinical Pharmacology, 67(1), 105–106.

    Article  PubMed  Google Scholar 

  • Bogunovic, O. J., & Greenfield, S. F. (2004). Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatric Services (Washington, D.C.), 55(3), 233–235.

    Article  PubMed  Google Scholar 

  • Bourgeois, J., Elseviers, M. M., van Bortel, L., Petrovic, M., & Vander Stichele, R. H. (2013). Sleep quality of benzodiazepine users in nursing homes: A comparative study with nonusers. Sleep Medicine, 14(7), 614–621.

    Article  PubMed  Google Scholar 

  • Cook, J. M., Marshall, R., Masci, C., & Coyne, J. C. (2007). Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. Journal of General Internal Medicine, 22(3), 303–307.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cumming, R. G., & Le Conteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people. CNS Drugs, 17(11), 825–837.

    Article  CAS  PubMed  Google Scholar 

  • Díaz-Gutiérrez, M. J., Martínez-Cengotitabengoa, M., de Adana, E. S., Cano, A. I., Martínez-Cengotitabengoa, M. T., Besga, A., et al. (2017). Relationship between the use of benzodiazepines and falls in older adults: A systematic review. Maturitas, 101, 17–22.

    Article  PubMed  Google Scholar 

  • Dou, C., Rebane, J., & Bardal, S. (2019). Interventions to improve benzodiazepine tapering success in the elderly: A systematic review. Aging & Mental Health, 23(4), 411–416.

    Article  Google Scholar 

  • Du, Y., Scheidt-Nave, C., & Knopf, H. (2008). Use of psychotropic drugs and alcohol among non-institutionalised elderly adults in Germany. Pharmacopsychiatry, 41(06), 242–251.

    Article  CAS  PubMed  Google Scholar 

  • Evrard, P., Henrard, S., Foulon, V., & Spinewine, A. (2020). Benzodiazepine use and deprescribing in belgian nursing homes: Results from the COME-ON Study. Journal of the American Geriatrics Society, 68(12), 2768–2777.

    Article  PubMed  Google Scholar 

  • Fourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001). Benzodiazepine use in an elderly community-dwelling population. European Journal of Clinical Pharmacology, 57(5), 419–425.

    Article  CAS  PubMed  Google Scholar 

  • Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ, 331(7526), 1169.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gupta, A., Bhattacharya, G., Balaram, K., Tampi, D., & Tampi, R. R. (2021). Benzodiazepine use among older adults: Future Medicine.

  • Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian journal of statistics, 65–70.

  • Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000). Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24(1), 7–10.

    Article  CAS  PubMed  Google Scholar 

  • Lader, M. (2011). Benzodiazepines revisited–Will we ever learn? Addiction (Abingdon, England), 106(12), 2086–2109.

    Article  PubMed  Google Scholar 

  • Linden, M., Bär, T., & Helmchen, H. (2004). Prevalence and appropriateness of psychotropic drug use in old age: Results from the Berlin Aging Study (BASE). International Psychogeriatrics, 16(4), 461–480.

    Article  PubMed  Google Scholar 

  • Liu, L., Jia, L., Jian, P., Zhou, Y., Zhou, J., Wu, F., & Tang, Y. (2020). The Effects of benzodiazepine use and abuse on cognition in the elders: A systematic review and meta-analysis of comparative studies. Frontiers in Psychiatry, 11, 755.

    Article  Google Scholar 

  • Mann, E., Böhmdorfer, B., Frühwald, T., Roller-Wirnsberger, R. E., Dovjak, P., Dückelmann-Hofer, C., et al. (2012). Potentially inappropriate medication in geriatric patients: The Austrian consensus panel list. Wiener Klinische Wochenschrift, 124(5–6), 160–169.

    Article  PubMed  Google Scholar 

  • Mathieu, C., Joly, P., Jacqmin-Gadda, H., Wanneveich, M., Bégaud, B., & Pariente, A. (2020). Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: A nationwide cohort study. Drug Safety, 1–10.

  • Moosmann, B., Hutter, M., Huppertz, L. M., Ferlaino, S., Redlingshöfer, L., & Auwärter, V. (2013). Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicology, 31(2), 263–271.

    Article  CAS  Google Scholar 

  • Mura, T., Proust-Lima, C., Akbaraly, T., Amieva, H., Tzourio, C., Chevassus, H., et al. (2013). Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city study. European Neuropsychopharmacology, 23(3), 212–223.

    Article  CAS  PubMed  Google Scholar 

  • Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136–142.

    Article  PubMed  Google Scholar 

  • Peters, F., Hartung, M., Herbold, M., SchmittDaldrup, G. T., & Mußhoff, F. (2009). Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech, 76(3), 185–208.

    Google Scholar 

  • Picton, J. D., Marino, A. B., & Nealy, K. L. (2018). Benzodiazepine use and cognitive decline in the elderly. American Journal of Health-System Pharmacy, 75(1), e6–e12. Retrieved September 29, 2021.

    Article  PubMed  Google Scholar 

  • Poly, T. N., Islam, M. M., Yang, H.-C., & Li, Y.-C.J. (2020). Association between benzodiazepines use and risk of hip fracture in the elderly people: A meta-analysis of observational studies. Joint, Bone, Spine, 87(3), 241–249.

    Article  CAS  PubMed  Google Scholar 

  • Ray, W. A., Thapa, P. B., & Gideon, P. (2000). Benzodiazepines and the risk of falls in nursing home residents. Journal of the American Geriatrics Society, 48(6), 682–685.

    Article  CAS  PubMed  Google Scholar 

  • Richter, T., Mann, E., Meyer, G., Haastert, B., & Köpke, S. (2012). Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. Journal of the American Medical Directors Association, 13(2), 187. e7-187. e13.

    Article  PubMed  Google Scholar 

  • Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E., & Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163(2), 70–72.

    Article  CAS  PubMed  Google Scholar 

  • Stevenson, D. G., Decker, S. L., Dwyer, L. L., Huskamp, H. A., Grabowski, D. C., Metzger, E. D., & Mitchell, S. L. (2010). Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey. The American Journal of Geriatric Psychiatry, 18(12), 1078–1092.

    Article  PubMed  PubMed Central  Google Scholar 

  • Taylor, S., McCracken, C. F., Wilson, K. C., & Copeland, J. R. (1998). Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. The British Journal of Psychiatry: The Journal of Mental Science, 173, 433–438.

    Article  CAS  PubMed  Google Scholar 

  • Tritt, K., von Heymann, F., Zaudig, M., Zacharias, I., Söllner, W., & Loew, T. (2008). Development of the “ICD-10-Symptom-Rating” (ISR) questionnaire. Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie, 54(4), 409–418.

    Article  PubMed  Google Scholar 

  • Tsunoda, K., Uchida, H., Suzuki, T., Watanabe, K., Yamashima, T., & Kashima, H. (2010). Effects of discontinuing benzodiazepine-Derivative hypnotics on postural sway and cognitive functions in the elderly. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 25(12), 1259–1265.

    Article  Google Scholar 

  • van Dijk, K. N., de Vries, C. S., van den Berg, P. B., Brouwers, J. J., & de Jong-van den Berg, L. T. (2000). Drug utilisation in Dutch nursing homes. European Journal of Clinical Pharmacology, 55(10), 765–771.

    Article  PubMed  Google Scholar 

  • van Vliet, P., van der Mast, R. C., van den Broek, M., Westendorp, R. G. J., & de Craen, A. J. M. (2009). Use of benzodiazepines, depressive symptoms and cognitive function in old age. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 24(5), 500–508.

    Article  Google Scholar 

  • Wu, C.-S., Wang, S.-C., Chang, I.-S., & Lin, K.-M. (2009). The association between dementia and long-term use of benzodiazepine in the elderly: Nested case–control study using claims data. The American Journal of Geriatric Psychiatry, 17(7), 614–620.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would also like to thank the staff and residents of all nursing homes for their participation in this project.

Funding

The authors gratefully acknowledge the funding provided by the European Regional Development Fund (Europäischer Fonds für regionale Entwicklung – EFRE). Furthermore, the Bavarian State Ministry of the Environment and Public Health, the Caritas Bad Reichenhall, and the Salzburg State Hospital provided financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monika Dreher-Weber.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dreher-Weber, M., Laireiter, AR., Kühberger, A. et al. Assessment of Benzodiazepine (BZD) Use Among Nursing Home Residents by Liquid Chromatography-Tandem Mass Spectrometry, Nursing Questionnaires, and Examining Additional Mental Health Problems of BZD Users. Int J Ment Health Addiction 21, 1713–1726 (2023). https://doi.org/10.1007/s11469-021-00685-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11469-021-00685-x

Keywords

Navigation